Cybin Inc. Stock OTC Markets
Stocks
CLXP.F
CA23256X1006
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.630 CAD | -6.07% |
|
+17.41% | +76.51% |
| 06-29 | Cybin Inc. Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 06-25 | Helus Pharma Closes $50 Million Underwritten Offering | MT |
| Market Cap | 630M 449M 393M 362M 334M 43.23B 644M 4.33B 1.7B 21.18B 1.69B 1.65B 72.9B | P/E 2027 * |
-2.67x | P/E 2028 * | -3.17x |
|---|---|---|---|---|---|
| Enterprise Value | 191M 136M 119M 110M 101M 13.12B 195M 1.31B 516M 6.43B 512M 501M 22.13B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 7.45x |
| Free-Float |
97.25% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Cybin Inc.
| 1 day | -6.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Glavine
COO | Chief Operating Officer | 37 | 2016-10-12 |
Eric So
CEO | Chief Executive Officer | 51 | 2026-04-19 |
Greg Cavers
DFI | Director of Finance/CFO | 56 | 2020-11-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric So
CHM | Chairman | 51 | 2020-11-04 |
Paul Glavine
BRD | Director/Board Member | 37 | 2016-10-12 |
Eric Hoskins
BRD | Director/Board Member | 65 | 2020-11-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.07% | +17.41% | - | - | 449M | |
| -7.17% | -4.39% | +45.51% | +79.00% | 52.1B | |
| +0.24% | -1.54% | +53.22% | +71.85% | 53.83B | |
| +0.80% | -6.31% | +3.98% | +423.29% | 23.48B | |
| -0.09% | -0.01% | -17.62% | -14.67% | 23.13B | |
| -5.95% | -2.58% | +30.67% | -9.58% | 19.36B | |
| -1.14% | +0.03% | +31.57% | -30.42% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +306.37% | 15.2B | |
| -6.91% | -5.83% | +26.53% | +636.97% | 14.83B | |
| +0.43% | -1.03% | +24.63% | +191.40% | 14.06B | |
| Average | -3.10% | -2.62% | +40.77% | +183.80% | 25.95B | |
| Weighted average by Cap. | -2.81% | -2.36% | +40.12% | +144.11% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 3.65M 2.6M 2.28M 2.1M 1.94M 251M 3.73M 25.1M 9.85M 123M 9.78M 9.56M 423M |
| Net income | -252M -180M -157M -145M -134M -17.32B -258M -1.73B -681M -8.49B -676M -661M -29.21B | -276M -197M -172M -159M -146M -18.94B -282M -1.9B -744M -9.28B -739M -723M -31.95B |
| Net Debt | -438M -313M -273M -252M -232M -30.1B -448M -3.02B -1.18B -14.75B -1.17B -1.15B -50.77B | -602M -429M -376M -346M -319M -41.36B -616M -4.14B -1.63B -20.27B -1.61B -1.58B -69.76B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HELP Stock
- CLXP.F Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
